GEN Exclusives

More »

GEN News Highlights

More »
Oct 10, 2006

DSM Biologics Provides Manufacturing Services to Argenes

  • DSM Biologics and Argenes signed a biopharmaceutical manufacturing agreement. Under the terms of the agreement, DSM Biologics will provide Argenes with full process development services, analytical development services, and manufacturing batches for Argenes’ Anti-Fas IgM Mab.

    Argenes’ Anti-FAS IgM Mab is being developed as an antirheumatic agent. The services will be provided out of DSM Biologics’ manufacturing facility in Groningen, The Netherlands.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »